Alkermes bolts on Rodin Therapeutics to bulk up thin pipelineAlkermes has agreed a $950 million deal to acquire Rodin Therapeutics, a US biotech developing drugs for neurodegenerative Share XAlkermes bolts on Rodin Therapeutics to bulk up thin pipelinehttps://pharmaphorum.com/news/alkermes-bolts-on-rodin-therapeutics-to-bulk-up-thin-pipeline/
Searching for new hope in Alzheimer’sFor the best part of two decades, it seemed as if pharma hit a brick wall as it Share XSearching for new hope in Alzheimer’shttps://pharmaphorum.com/r-d/views-analysis-r-d/searching-for-new-hope-in-alzheimers/
Combating chronic diseases through technology and collaborationBy 2050, 2.1bn people globally will be aged 60 or over. That’s more than double the 962m recorded in 2017. This lengthening of life is closely Share XCombating chronic diseases through technology and collaborationhttps://pharmaphorum.com/digital/combating-chronic-diseases-through-technology-and-collaboration/
The challenges of measuring dementiaOxford Brain Diagnostic’s Dr Steven Chance explains the importance of early detection of dementia for treatment and research, Share XThe challenges of measuring dementiahttps://pharmaphorum.com/views-and-analysis/the-challenges-of-measuring-dementia/
Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
Pilot study suggests smart devices could help spot early dementiaA preliminary study run by Eli Lilly, Apple and Evidation has suggested that connected smart devices can detect Share XPilot study suggests smart devices could help spot early dementiahttps://pharmaphorum.com/news/pilot-study-suggests-smart-devices-could-help-spot-early-dementia/
Finding the big picture for Alzheimer’sThe $4m Oskar Fischer Prize hopes to catalyse a breakthrough in Alzheimer’s research by encouraging a ‘big picture’ Share XFinding the big picture for Alzheimer’shttps://pharmaphorum.com/r-d/views-analysis-r-d/finding-the-big-picture-for-alzheimers/
AI test detects early signs of dementiaA pioneering artificial intelligence (AI) computer test can help detect whether individuals are in the early stages of Share XAI test detects early signs of dementiahttps://pharmaphorum.com/news/ai-test-detects-early-signs-of-dementia/
Eisai accelerates dementia drug discovery researchEisai is launching a special dementia discovery centre to boost development of next-generation medicines targeting forms of the Share XEisai accelerates dementia drug discovery researchhttps://pharmaphorum.com/news/eisai-dementia-drug-research/
